IXC
Click for more information
2.86% 7.2¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3

  1. edb11
    190 Posts.
    lightbulb Created with Sketch. 22
    clock Created with Sketch.
    04/11/21
    09:19
    Post #: 57303138
    Pragmatic approach. Not the Big Bang we wanted, but I like that management have taken action. Let’s get this ball rolling.
    IXC Price at posting: 65.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LU7 Filling the Lithium Conversion Gap: Lithium Universe commits to community collaboration through formation of joint committee for Bécancour
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
UNT UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢ 		Change
0.002(2.86%) 		Mkt cap ! $5.411M
Open High Low Value Volume
7.0¢ 7.2¢ 6.6¢ $3.476K 50.58K

Buyers (Bids)

No. Vol. Price($)
1 29320 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.58pm 23/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.